Testing effectiveness (Phase 2)Study completedNCT00732771
What this trial is testing
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
Who this might be right for
Primary Hyperaldosteronism
Novartis 12